EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
EGFR 和 MET 扩增决定 ERBB2 扩增型食管胃癌对 HER2 抑制剂的反应
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-18-0598
Sanchez-Vega, Francisco; Hechtman, Jaclyn F; Castel, Pau; Ku, Geoffrey Y; Tuvy, Yaelle; Won, Helen; Fong, Christopher J; Bouvier, Nancy; Nanjangud, Gouri J; Soong, Joanne; Vakiani, Efsevia; Schattner, Mark; Kelsen, David P; Lefkowitz, Robert A; Brown, Karen; Lacouture, Mario E; Capanu, Marinela; Mattar, Marissa; Qeriqi, Besnik; Cecchi, Fabiola; Tian, Yuan; Hembrough, Todd; Nagy, Rebecca J; Lanman, Richard B; Larson, Steven M; Pandit-Taskar, Neeta; Schöder, Heiko; Iacobuzio-Donahue, Christine A; Ilson, David H; Weber, Wolfgang A; Berger, Michael F; de Stanchina, Elisa; Taylor, Barry S; Lewis, Jason S; Solit, David B; Carrasquillo, Jorge A; Scaltriti, Maurizio; Schultz, Nikolaus; Janjigian, Yelena Y
胃癌
肿瘤
HER2
肿瘤免疫
ERBB2
EGF
EGFR
MET